Steven B Ratoff's Net Worth
-$411 Thousand
Who is Steven B Ratoff?
Steven B Ratoff does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include EAGLE PHARMACEUTICALS, INC., TorreyPines Therapeutics, Inc., NOVADEL PHARMA INC, CIMA LABS INC, and INKINE PHARMACEUTICAL CO INC.
SEC CIK
Steven B Ratoff's CIK is 0001054941
Past Insider Trading and Trends
2004 was Steven B Ratoff's most active year for acquiring shares with 17 total transactions. Steven B Ratoff's most active month to acquire stocks was the month of September. 2004 was Steven B Ratoff's most active year for disposing of shares, totalling 26 transactions. Steven B Ratoff's most active month to dispose stocks was the month of September. 2006 saw Steven B Ratoff paying a total of $550,068.20 for 441,975 shares, this is the most they've acquired in one year. In 2016 Steven B Ratoff cashed out on 10,000 shares for a total of $750,091.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
EAGLE PHARMACEUTICALS, INC. (EGRX) Snapshot price: $5.57
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
| +34.51% | 7.02K |
$7.33 | $51,433.20 | 27.36K |
Apr 8
| |||
Form 4
| +13.00% | 2.34K |
$8.78 | $20,545.20 | 20.34K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 5
| |||
Form 4
| +14.94% | 2.34K |
$4.04 | $9,453.60 | 18K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 7
| |||
Form 4
| +17.56% | 2.34K |
$0.90 | $2,106.00 | 15.66K |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| -31.23% | -6.05K |
$43.90 | -$699,570.50 | 13.32K |
Apr 3 - Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
| +106.99% | 10.01K |
—
|
—
| 19.37K |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
NOVADEL PHARMA INC No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +178.57% | 1M |
$0.16 | $159,210.89 | 1.56M |
Dec 8 - Dec 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
| +115.38% | 300K |
—
|
—
| 560K |
Feb 6
| |||
Form 4
| +2.33% | 5.91K |
$0.73 | $4,313.94 | 260K |
Aug 28
| |||
Form 4
| +2.54% | 6.3K |
$0.65 | $4,095.00 | 254.09K |
Aug 24
| |||
Form 4
| +18.85% | 39.3K |
$0.65 | $25,545.00 | 247.79K |
Aug 23
| |||
Form 4
| +2.16% | 4.4K |
$0.64 | $2,830.08 | 208.49K |
Aug 22
| |||
Form 4
| +32.45% | 50K |
$0.61 | $30,350.00 | 204.09K |
Aug 21
| |||
Form 4
| +19.37% | 25K |
$0.60 | $14,925.00 | 154.09K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 16
| |||
Form 4
|
∞
| 129.09K |
$1.58 | $203,962.20 | 129.09K |
Apr 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TorreyPines Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
| +159.87% | 49.96K |
$6.93 | $346,106.00 | 81.21K |
Dec 26 - Dec 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
∞
| 250K |
$1.19 | $298,521.90 | 250K |
May 16 - May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CIMA LABS INC No price found
Chairman and Interim CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -6.30K |
$34.00 | -$214,200.00 |
0
|
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11 - Jun 18
| |||
| No matching records found | |||||||||
INKINE PHARMACEUTICAL CO INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
| No matching records found | |||||||||